WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007089683) AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/089683    International Application No.:    PCT/US2007/002360
Publication Date: 09.08.2007 International Filing Date: 30.01.2007
IPC:
C07D 211/42 (2006.01), C07D 211/46 (2006.01), C07D 211/96 (2006.01), C07D 405/12 (2006.01), C07D 451/06 (2006.01), C07D 451/14 (2006.01), C07D 491/18 (2006.01), C07D 413/12 (2006.01), A61K 31/439 (2006.01), A61P 3/00 (2006.01), A61P 9/00 (2006.01), A61K 31/445 (2006.01)
Applicants: INCYTE CORPORATION [US/US]; Experimental Station, Experimental Station, Route 141 & Henry Clay Road, Building E336, Wilmington, Delaware 19880 (US) (For All Designated States Except US).
LI, Yun-Long [CN/US]; (US) (For US Only).
YAO, Wenqing [CN/US]; (US) (For US Only).
ZHUO, Jincong [CN/US]; (US) (For US Only)
Inventors: LI, Yun-Long; (US).
YAO, Wenqing; (US).
ZHUO, Jincong; (US)
Agent: GODDARD, Christine, A.; Fish & Richardson P.C., PO Box 1022, Minneapolis, MN 55440-1022 (US)
Priority Data:
60/763,726 31.01.2006 US
60/808,680 26.05.2006 US
Title (EN) AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS
(FR) COMPOSÉS AMIDO ET LEUR UTILISATION COMME PRODUITS PHARMACEUTIQUES
Abstract: front page image
(EN)The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type l, as exemplified by formula (I).
(FR)La présente invention concerne des inhibiteurs de la 11-ß-hydroxystéroïde déshydrogénase de type 1 et des compositions pharmaceutiques de ces inhibiteurs. Les composés de l'invention peuvent être utiles dans le traitement de diverses maladies associées à l'expression ou à l'activité de la 11-ß-hydroxystéroïde déshydrogénase de type 1.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)